FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / Deal Tables / Deal List / Deal Details

The ABL Advisor Deal Tables

JPMorgan Chase Agents $1.3B in Financing for Catalent Pharma Solutions
Tuesday, May 21, 2019

Lenders/Participants JPMorgan Chase Bank [Administrative Agent, Collateral Agent]
Structure Term Loan, Revolver Increase
Amount $1.300 Billion
Borrower(s) Catalent Pharma Solutions, Inc.
Description Catalent, Inc. completed the acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies. In connection with the acquisition of Paragon, Catalent Pharma Solutions, Inc., as borrower, and certain other wholly owned subsidiaries of Catalent entered into an amendment, dated as of May 17, 2019, to its existing credit agreement with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, to provide for, among other things, $950 million of incremental term loans and a $350 million increase to its revolving credit facility. The proceeds of the incremental term loans were used to fund a portion of the acquisition consideration and for general working capital purposes, to pay fees, costs and expenses incurred in connection with the transactions contemplated hereby, for capital expenditures of Paragon and to prepay a portion of the existing term loans.
Industry Biologics
Location NJ
Related Tags JPMorgan Chase Bank

ABL Advisor
Deal Tables 2019
Thomson Reuters LPC
League Tables
Thomson Reuters LPC
Loan Volume Reports